Uptake of COVID-19 vaccination among community-dwelling individuals receiving healthcare for substance use disorder and major mental illness: a matched retrospective cohort study
Frontiers in Public Health · 2024
DOI: 10.3389/fpubh.2024.1426152 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Public Health, 2024. Verfasst von Lucie Richard und 4 weiteren Autor:innen. Beteiligte Einrichtung: MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: COVID-19, Substance-Related Disorders, Mental Disorders, Independent Living. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Introduction
Patients with major mental illness (MMI) and substance use disorders (SUD) face barriers in accessing healthcare. In this population-based retrospective cohort study, we investigated the uptake of COVID-19 vaccination in Ontario, Canada among community-dwelling individuals receiving healthcare for major mental illness (MMI) and/or substance use disorders (SUD), comparing them to matched general population controls.
Methods
Using linked health administrative data, we identified 337,290 individuals receiving healthcare for MMI and/or SUD as of 14 December 2020, matched by age, sex, and residential geography to controls without such healthcare. Follow-up extended until 31 December 2022 to document vaccination events.
Results
Overall, individuals receiving healthcare for MMI and/or SUD ( N = 337,290) had a slightly lower uptake of first (cumulative incidence 82.45% vs. 86.44%; hazard ratio [HR] 0.83 [95% CI 0.82–0.83]) and second dose (78.82% vs. 84.93%; HR 0.77 [95% CI 0.77–0.78]) compared to matched controls. Individuals receiving healthcare for MMI only ( n = 146,399) had a similar uptake of first (87.96% vs. 87.59%; HR 0.97 [95% CI 0.96–0.98]) and second dose (86.09% vs. 86.05%, HR 0.94 [95% CI 0.93–0.95]). By contrast, individuals receiving healthcare for SUD only ( n = 156,785) or MMI and SUD ( n = 34,106) had significantly lower uptake of the first (SUD 78.14% vs. 85.74%; HR 0.73 [95% CI 0.72–0.73]; MMI & SUD 78.43% vs. 84.74%; HR 0.76 [95% CI 0.75–0.77]) and second doses (SUD 73.12% vs. 84.17%; HR 0.66 [95% CI 0.65–0.66]; MMI & SUD 73.48% vs. 82.93%; HR 0.68 [95% CI 0.67–0.69]).
Discussion
These findings suggest that effective strategies to increase vaccination uptake for future COVID-19 and other emerging infectious diseases among community-dwelling people with SUD are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, ON, Canada.
- Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.
- ICES, Toronto, ON, Canada.
- Department of Medicine, University of Toronto, Toronto, ON, Canada.
Zitieren
APA
Richard, L., Holland, A., Aghanya, V., Campitelli, M. A., & Hwang, S. W. (2024). Uptake of COVID-19 vaccination among community-dwelling individuals receiving healthcare for substance use disorder and major mental illness: a matched retrospective cohort study. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2024.1426152
Vancouver
Richard L, Holland A, Aghanya V, Campitelli MA, Hwang SW. Uptake of COVID-19 vaccination among community-dwelling individuals receiving healthcare for substance use disorder and major mental illness: a matched retrospective cohort study. Frontiers in Public Health. 2024. doi:10.3389/fpubh.2024.1426152
BibTeX
@article{Richard2024,
author = {Richard, Lucie and Holland, Anna and Aghanya, Vivian and Campitelli, Michael A and Hwang, Stephen W},
title = {Uptake of COVID-19 vaccination among community-dwelling individuals receiving healthcare for substance use disorder and major mental illness: a matched retrospective cohort study},
journal = {Frontiers in Public Health},
year = {2024},
doi = {10.3389/fpubh.2024.1426152}
}
EUVIMED